Aurinia Pharmaceuticals Inc.

Ensign Peak Advisors, Inc AUPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

10,085

Value ($000)

161

Weight

0.0%

2020 Q2 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	161	0.0%	10,085	12/31/2025
2025 Q3	11/13/2025	363	0.0%	32,835	9/30/2025
2025 Q2	8/12/2025	540	0.0%	63,735	6/30/2025
2025 Q1	5/14/2025	512	0.0%	63,735	3/31/2025
2024 Q4	2/14/2025	572	0.0%	63,735	12/31/2024
2024 Q3	11/14/2024	467	0.0%	63,735	9/30/2024
2024 Q2	8/13/2024	364	0.0%	63,735	6/30/2024
2024 Q1	5/14/2024	319	0.0%	63,735	3/31/2024
2023 Q4	2/14/2024	602	0.0%	66,950	12/31/2023
2023 Q3	11/13/2023	382	0.0%	49,100	9/30/2023
2023 Q2	8/14/2023	343	0.0%	35,450	6/30/2023
2022 Q3	11/14/2022	302	0.0%	40,150	9/30/2022
2022 Q2	8/12/2022	329	0.0%	32,710	6/30/2022
2022 Q1	5/16/2022	405	0.0%	32,710	3/31/2022
2021 Q4	2/11/2022	711	0.0%	31,070	12/31/2021
2021 Q3	11/12/2021	2,904	0.0%	131,203	9/30/2021
2021 Q2	8/13/2021	1,965	0.0%	151,599	6/30/2021
2021 Q1	5/12/2021	1,312	0.0%	101,059	3/31/2021
2020 Q4	2/12/2021	1,291	0.0%	93,357	12/31/2020
2020 Q3	11/12/2020	1,010	0.0%	68,525	9/30/2020
2020 Q2	8/12/2020	254	0.0%	15,653	6/30/2020